• Abiraterone acetate Tablets

    Free

    Product Composition & Strength

    We supply this product in standardized strengths designed for high-dose oncology regimens.

    Active IngredientStrengthPrimary Clinical Function
    Abiraterone Acetate USP/Ph.Eur.250 mgThe Standard Unit: Used in a 4-tablet daily regimen to reach the 1000 mg therapeutic dose.
    Abiraterone Acetate USP/Ph.Eur.500 mgThe High-Compliance Unit: Reduces “pill burden” for elderly patients (2 tablets daily).
    ExcipientsMicronized MatrixEnhanced Bioavailability: Engineered to ensure consistent absorption of this lipophilic (fat-soluble) molecule.
  • Afatinib Tablets

    Free

    Product Composition & Strength

    We supply this product in multiple strengths to allow for precise dose titration based on patient tolerability.

    Active IngredientStrengthPrimary Clinical Function
    Afatinib (as Dimaleate) USP/Ph.Eur.20 mg / 30 mgThe Dose-Adjustment Unit: Used for patients requiring a lower dose due to gastrointestinal or skin toxicity.
    Afatinib (as Dimaleate) USP/Ph.Eur.40 mgThe Standard Therapeutic Anchor: The globally validated starting dose for first-line treatment of EGFR+ NSCLC.
    ExcipientsProprietary MatrixBio-Stable Coating: Engineered to protect the sensitive dimaleate salt and ensure consistent systemic absorption.
  • Alpelisib Tablets

    Free

    Product Composition & Strength

    We supply this product in standardized daily dose packs, designed to achieve the 300 mg daily therapeutic target.

    Active IngredientStrengthPrimary Clinical Function
    Alpelisib USP/Ph.Eur.50 mg / 150 mgThe Combination Unit: Used together (150mg x 2) to reach the standard 300mg daily dose.
    Alpelisib USP/Ph.Eur.200 mgThe Dose-Reduction Unit: Used for patients requiring a lower dose due to side effects (Hyperglycemia/Rash).
    ExcipientsProprietary MatrixBio-Stable Coating: Engineered to protect the sensitive API and ensure consistent systemic absorption.
  • Altretamine Capsules

    Free

    Altretamine capsules are antineoplastic (chemotherapy) medications used primarily for the palliative treatment of advanced ovarian cancer. They are most commonly available in a 50 mg strength.

  • Anastrozole Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.

    Active IngredientStrengthPrimary Clinical Function
    Anastrozole USP/Ph.Eur.1 mgThe Standard Oncology Anchor: The globally validated dose for both adjuvant and first-line treatment of advanced breast cancer.
    ExcipientsProprietary MatrixHigh-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust, ensuring safety for healthcare workers.
  • Azathioprine Tablets

    Free

    ATHEPRIN TABLETS
    Azathioprine Tablets IP 50 mg
    Each Uncoated Tablet Contains :
    Azathioprine IP 50 mg

    Usage: – Prevent organ rejection in people who have received a kidney transplant

    Category: – Arthritis drugs

    Therapeutic category: – Arthritis

  • Bicalutamide Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.

    Active IngredientStrengthPrimary Clinical Function
    Bicalutamide USP/Ph.Eur.50 mgThe Metastatic Anchor: Used in combination with a LHRH analogue (medical castration) for advanced metastatic disease.
    Bicalutamide USP/Ph.Eur.150 mgThe Monotherapy Payload: Utilized as a standalone treatment for locally advanced, non-metastatic prostate cancer.
    ExcipientsProprietary MatrixHigh-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust during handling by healthcare professionals.
  • Capecitabine Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.

    Active IngredientStrengthPrimary Clinical Function
    Capecitabine USP/Ph.Eur.150 mgThe Precision Titration Anchor: Utilized for accurate dose adjustments based on Body Surface Area (BSA).
    Capecitabine USP/Ph.Eur.500 mgThe Oncology Macrodose: The primary therapeutic unit for standard cycles in Colorectal and Breast cancer.
    ExcipientsProprietary MatrixHigh-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust during handling by healthcare professionals.
  • Chlorambucil Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Low-Dose Cytotoxic Tablet, packed exclusively in light-shielded, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the sensitive aromatic mustard payload.

    Active IngredientStrengthPrimary Clinical Function
    Chlorambucil USP/Ph.Eur.2 mgThe Standard Hematology Anchor: The definitive unit utilized for chronic, daily maintenance and precise titration in CLL and low-grade lymphomas.
    Chlorambucil USP/Ph.Eur.5 mgThe Pulse-Dosing Payload: High-efficacy therapeutic payload utilized for “Pulse” therapy regimens or initial aggressive induction phases.
    ExcipientsLactose Anhydrous / Colloidal Silicon Dioxide / Magnesium Stearate / Hypromellose / Titanium Dioxide / Premium Polymeric FilmDiluent / Glidant / Lubricant / Protective Cytotoxic Shield (Engineered specifically utilizing an impenetrable film coat. This ensures the highly toxic, mutagenic API never comes into contact with the skin of the pharmacist or caregiver handling the medication).

    *Pack Sizes: 25-Tablet or 30-Tablet Bottles/Blisters (Optimized for oncology-specific treatment cycles).

  • Cyclophosphamide Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Cytotoxic Prodrug Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the sensitive nitrogen mustard derivative and to physically protect caregivers from API exposure.

    Active IngredientStrengthPrimary Clinical Function
    Cyclophosphamide USP/Ph.Eur.
    (as Cyclophosphamide Monohydrate)
    50 mgThe Oncology & Autoimmune Macrodose: The definitive oral therapeutic unit utilized for chronic, daily continuous “metronomic” chemotherapy regimens and severe immunosuppressive maintenance.
    ExcipientsLactose Monohydrate / Microcrystalline Cellulose / Starch / Magnesium Stearate / Heavy Sucrose or Polymeric Film-CoatDiluent / Densifier / Disintegrant / Lubricant / Protective Cytotoxic Shield (Engineered specifically utilizing a thick, impenetrable sugar or film coat to ensure the highly toxic API never comes into contact with the skin of the patient, pharmacist, or caregiver handling the pill)

    *Pack Sizes: Bottles of 50/100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic oncology and rheumatology dispensing regimens).

  • Estramustine Phosphate Capsules

    Free

    Estramustine phosphate capsules typically contain estramustine phosphate sodium as the active medicinal ingredient, along with several inactive excipients to ensure the drug’s stability and delivery.

  • Everolimus Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Antioxidant-Stabilized Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the highly oxidative, potent API.

    Active IngredientStrengthPrimary Clinical Function
    Everolimus USP/Ph.Eur.0.25 mg / 0.5 mg / 0.75 mgGlobal Transplant Standard: Ultra-micro doses utilized for strict, lifelong immunosuppression following renal or hepatic allografts. Requires extreme content uniformity to maintain the narrow therapeutic blood trough levels (3 to 8 ng/mL).
    Everolimus USP/Ph.Eur.5 mg / 10 mgGlobal Oncology Standard: Massive-dose antineoplastic payload utilized for the aggressive suppression of Renal Cell Carcinoma, Neuroendocrine Tumors (NETs), and HR+/HER2- Breast Cancer.
    ExcipientsButylated Hydroxytoluene (BHT) / Hypromellose / Lactose Anhydrous / Crospovidone / Magnesium StearateAntioxidant / Binder / Diluent / Superdisintegrant / Lubricant (Engineered specifically utilizing BHT (Butylated Hydroxytoluene) to prevent the rapid oxidative degradation of the Everolimus molecule, guaranteeing maximum clinical shelf-life and potency across harsh climates)

    *Pack Sizes: 10×10 Alu-Alu Blisters (Transplant) or 3×10 Alu-Alu Blisters (Oncology – 30 Day Supply).

  • Exemestane Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the potent steroidal antineoplastic agent.

    Active IngredientStrengthPrimary Clinical Function
    Exemestane USP/Ph.Eur.25 mgGlobal Adult Oncology Standard: The definitive daily maintenance dose required to maintain absolute, continuous destruction of peripheral aromatase enzymes and keep estrogen levels crashed.
    ExcipientsMannitol / Copovidone / Crospovidone / Sodium Starch Glycolate / Magnesium Stearate / Premium Polymeric FilmDiluent / High-Shear Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the highly potent, teratogenic steroidal API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous dust)

    *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).

  • Imatinib Capsules

    Free

    Imatinib capsules contain the active oncology drug and a specific set of inactive ingredients designed to stabilize the compound for oral delivery.

  • Lenalidomide Capsules

    Free

    Lenalidomide capsules (brand name Revlimid) are a potent immunomodulatory medication used to treat certain types of cancers, such as multiple myeloma and myelodysplastic syndromes.

  • Letrozole tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the micro-dosed endocrine disruptor.

    Active IngredientStrengthPrimary Clinical Function
    Letrozole USP/Ph.Eur.2.5 mgGlobal Oncology & Fertility Standard: The universal therapeutic unit utilized for 5-to-10 year daily adjuvant breast cancer therapy, or short 5-day cyclic dosing for ovulation induction.
    ExcipientsLactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry FilmDiluent / Binder / Superdisintegrant / Glidant / Slipper-Coating (Engineered specifically using elite geometric dilution to ensure the microscopic 2.5mg active payload is flawlessly distributed throughout the tablet, guaranteeing absolute content uniformity)

    *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict, heavily monitored chronic oncology dispensing or monthly fertility cycles).

  • Mercaptopurine Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, handler-protective Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antimetabolite and protect healthcare workers from cytotoxic exposure.

    Active IngredientStrengthPrimary Clinical Function
    Mercaptopurine (as Monohydrate) USP/Ph.Eur.50 mgGlobal Oncology & Autoimmune Standard: Scored tablets allowing for highly precise, weight-based or Body Surface Area (BSA) based dose titrations in pediatric and adult populations.
    ExcipientsLactose Monohydrate / Maize Starch / Pregelatinized Starch / Magnesium Stearate / Stearic AcidDiluent / Binder / Disintegrant / Lubricant (Engineered specifically using high-containment wet granulation to prevent airborne cytotoxic dust generation during manufacturing, ensuring precise, even API distribution)

    *Pack Sizes: Bottles of 25/50 or 10×10 Blisters (Optimized specifically for strict, heavily monitored chronic oncology dispensing regimens).

  • Methotrexate Injection

    Free

    Product Composition & Strength

    We supply this product as a Sterile Isotonic Solution (Ready-to-Use) or Lyophilized Powder (High Dose).

    Active IngredientStrengthCommon Application
    Methotrexate USP/BP2.5 mg / mlLow Dose (Rheumatology/Dermatology)
    Methotrexate USP/BP25 mg / mlStandard Oncology Dose
    Methotrexate USP/BP50 mg / 500 mg / 1 gHigh Dose MTX (Leukemia Protocols)
    PreservativeBenzyl AlcoholPresent in Multi-dose Vials (Avoid in IT use)

    *Pack Sizes: 2 ml Vial, 20 ml Vial, or 50 ml Vial.

  • Mitomycin Injection

    Free

    Product Composition & Strength

    We supply this product as a Sterile Lyophilized Powder (Purple/Blue Cake) in amber glass vials.

    Active IngredientStrengthPrimary Use
    Mitomycin USP/BP2 mgOphthalmic Surgery / Pterygium
    Mitomycin USP/BP10 mgSystemic Chemotherapy / Bladder Instillation
    Mitomycin USP/BP20 mg / 40 mgHigh-Dose Bladder Protocols
    ExcipientsMannitolBulking Agent

    *Pack Sizes: Single Vial. (Must be handled with cytotoxic precautions).

  • Ondansetron Orally Disintegrating Tablets

    Free

    Ondansetron orally disintegrating tablets usp 4mg
    Each uncoated orally disintegrating tablet contains:
    Ondansetron hydrochloride USP
    Eq. Anhydrous Ondansetron 4 mg

    Usage: – Trigger nausea and vomiting

    Category: – Antacid & Anti ulcer drugs

    Therapeutic category: – Antiemetic, Anti Vomiting

  • Oxaliplatin Injection

    Free

    Product Composition & Strength

    We supply this product as a Sterile, Clear, Aqueous Concentrate in glass vials. (Also available as Lyophilized Powder depending on market preference).

    Active IngredientStrengthVolume
    Oxaliplatin USP/BP5 mg / ml10 ml Vial (Total 50 mg)
    Oxaliplatin USP/BP5 mg / ml20 ml Vial (Total 100 mg)
    ExcipientsWater for InjectionPreservative-Free Solution

    *Pack Sizes: Single Vial. (Must be handled with strict cytotoxic precautions).

  • Pazopanib Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered, High-Density Film-Coated Tablet, packed exclusively in highly secure, child-resistant heavy-gauge HDPE bottles or specialized Alu-Alu blister strips to ensure the absolute chemical stability of the cytotoxic molecule and prevent accidental exposure.

    Active IngredientStrengthPrimary Clinical Function
    Pazopanib HCl INN/Ph.Eur.200 mg (Base Equivalent)Dose-Modification Standard: Essential unit for precise dose reduction in patients experiencing severe hepatic toxicity or adverse drug reactions.
    Pazopanib HCl INN/Ph.Eur.400 mg (Base Equivalent)Global Clinical Standard: Primary therapeutic unit designed to achieve the massive 800 mg daily protocol with minimal pill burden.
    ExcipientsMicrocrystalline Cellulose / Sodium Starch Glycolate / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium DioxideDiluent / Superdisintegrant / Binder / Lubricant / Premium Cytotoxic-Barrier Film-Coating (Engineered specifically to seal the lethal HPAPI inside the tablet, completely protecting healthcare workers and caregivers from highly toxic dust exposure)

    *Pack Sizes: Bottles of 30 or 60 Tablets (Optimized specifically for strict 30-day chronic oncology dispensing regimens).

  • Pemetrexed Injection

    Free

    Product Composition & Strength

    We supply this product as a Sterile Lyophilized Powder (White to Light-Yellow Cake) in glass vials.

    Active IngredientStrengthReconstitution
    Pemetrexed Disodium100 mgRequires 0.9% Sodium Chloride
    Pemetrexed Disodium500 mgRequires 0.9% Sodium Chloride
    Pemetrexed Disodium1000 mg (1 g)High-Dose Protocols
    ExcipientsMannitol / Hydrochloric Acid / Sodium HydroxideBulking Agent / pH Adjusters (pH 6.6 – 7.8)

    *Pack Sizes: Single Vial. (Must be handled with strict cytotoxic precautions).

  • Sorafenib tablets 200mg

    Free

    Sorafenib 200mg tablet is an oral multi-kinase inhibitor primarily containing Sorafenib as the active substance. It is used as a targeted therapy to treat advanced kidney cancer (renal cell carcinoma), liver cancer (hepatocellular carcinoma), and certain types of thyroid cancer.

  • Tamoxifen citrate Tablets

    Free

    Tamoxifen citrate tablet is a selective estrogen receptor modulator (SERM) typically prescribed for the treatment and prevention of hormone receptor-positive breast cancer.

  • Tamoxifen Tablet

    Free

    Tamoxifen tablet is a hormone-based medication used primarily to treat and prevent hormone receptor-positive breast cancer. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs)

  • Temozolamide tablets

    Free

    Temozolomide is primarily available as an oral capsule, though it is occasionally referred to as a “tablet” in some regions. It is a chemotherapy agent used to treat specific types of brain cancer, such as glioblastoma multiforme and anaplastic astrocytoma.

  • Temozolomide Capsules

    Free

    Temozolomide capsules are oral chemotherapy agents used primarily to treat specific types of brain tumours, such as glioblastoma multiforme and anaplastic astrocytoma. Because temozolomide is a hazardous drug, the capsules are designed to be swallowed whole to prevent direct exposure to the potent active ingredient.

  • Thioguanine (6-TG) 40 mg Tab.

    Free

    Thioguanine (6-TG) 40 mg tablets primarily contain 40 mg of Thioguanine as the active pharmaceutical ingredient. It is a cytotoxic chemotherapy medication, specifically a purine analog, used to treat acute leukemias.

  • Thioguanine Tablets

    Free

    Product Composition & Strength

    We supply this product in the globally standardized 40 mg strength, optimized for adult and pediatric weight-based dosing.

    Active IngredientStrengthPrimary Clinical Function
    Thioguanine USP/Ph.Eur.40 mgThe DNA Saboteur: Mimics guanine to stop the replication of leukemic cells.
    ExcipientsPharmaceutical GradeStability Matrix: Engineered to protect the sensitive API from environmental degradation.
  • Vinblastine Sulphate Injection

    Free

    Product Composition & Strength

    We supply this product as a Sterile Lyophilized Powder (White to Off-White) or as a Ready-to-Use Liquid Solution in glass vials.

    Active IngredientStrength & FormatReconstitution / Dilution
    Vinblastine Sulphate USP/BP10 mg / 10 ml (Liquid)Ready-to-use solution (1 mg/ml). Requires further dilution in 0.9% NaCl before infusion.
    Vinblastine Sulphate USP/BP10 mg (Lyophilized Powder)Requires exactly 10 ml of Bacteriostatic 0.9% Sodium Chloride to yield 1 mg/ml.
    ExcipientsSodium Chloride / Water for InjectionIsotonicity / Solvent System

    *Pack Sizes: Single Vial encased in specialized protective cytotoxic shrink-wrap

  • Vincristine Sulphate Injection

    Free

    Vincristine sulphate injection (often known by the brand Oncovin) is a sterile, preservative-free solution of vinca alkaloid chemotherapy agent derived from the periwinkle plant. It is a clear, colourless liquid typically supplied in 1 mg or 2 mg vials.